Tetrahydrocannabinol

Panacea Life Sciences CBD Expansion Plans to Golden in Full Swing

Retrieved on: 
Tuesday, March 5, 2019

GOLDEN, Colo., March 5, 2019 /PRNewswire/ -- Panacea Life Sciences further entrenches into the cannabinoid (CBD) marketplace with their acquisition of the 43,000 square foot former EPA building in Golden, Colorado.

Key Points: 
  • GOLDEN, Colo., March 5, 2019 /PRNewswire/ -- Panacea Life Sciences further entrenches into the cannabinoid (CBD) marketplace with their acquisition of the 43,000 square foot former EPA building in Golden, Colorado.
  • Panacea is proud to build their CBD Center of Excellence to use creativity and innovation to develop new CBD products with an emphasis on solving medical needs in humans and pets.
  • And, although today we adhere to Good Manufacturing Practice standards, we are excited to become fully GMP certified," explained Dr. James Baumgartner, President of Panacea Life Sciences.
  • Panacea offers a line of THC-free human and animal CBD products, such as sublingual tablets, soft gels and topicals.

Rapid Growth of CBD Infused Products Market may Spur Consolidation of Distribution Channels

Retrieved on: 
Wednesday, February 27, 2019

So far, it looks like the shelves and shopping carts are going to demand a more diverse and quickly replenishable supply of CBD infused products.

Key Points: 
  • So far, it looks like the shelves and shopping carts are going to demand a more diverse and quickly replenishable supply of CBD infused products.
  • can ship CBD products anywhere in the U.S., as long as the plant source meets that legal definition of industrial hemp and includes less than 0.3-percent THC.
  • The article continues with "It's amazing to see the growth that's happened already, and it's only the organizations getting in that have some bravery to them."
  • Shareholders that purchased common shares on the OTC Markets Pink Open Market may now trade their shares on the NYSE.

Innovus Pharma’s Subsidiary, Novalere, Inc., Announces Launch of Its First Hemp-Derived Cannabidiol Oil-Based Product, MZS Sleeping Aid™ in the United States

Retrieved on: 
Tuesday, February 26, 2019

MZS Sleeping Aid has been launched in states in the U.S. where hemp-derived CBD products may be sold.

Key Points: 
  • MZS Sleeping Aid has been launched in states in the U.S. where hemp-derived CBD products may be sold.
  • In accordance with current regulations the Company will not sell this product in any states where it is illegal to do so.
  • The product does not contain any Tetrahydrocannabinol (THC) and is designed to be compliant with applicable U.S. state and federal laws.
  • We are excited to announce the launch of our MZS Sleeping Aid product, said Dr. Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma.

Green Gorilla Launches New Pure CBD Lip Balm Made With Certified Organic Ingredients

Retrieved on: 
Thursday, February 21, 2019

LOS ANGELES, Feb. 21, 2019 /PRNewswire/ --Green Gorilla, a leading manufacturer and brand of CBD products, has launched a new pure CBD lip balm made with Certified Organic ingredients that is now available online and at retail locations across the country.

Key Points: 
  • LOS ANGELES, Feb. 21, 2019 /PRNewswire/ --Green Gorilla, a leading manufacturer and brand of CBD products, has launched a new pure CBD lip balm made with Certified Organic ingredients that is now available online and at retail locations across the country.
  • The Green Gorilla lip balm contains 20mg of pure CBD and comes in a .15oz tube for easy application.
  • Green Gorilla pure CBD products are USDA NOP certified organic, non-GMO, vegan, kosher, paleo, gluten-free, sugar-free and THC-free and never contain artificial dyes, coloring, preservatives or additives of any kind.
  • Green Gorilla is an international brand in the hemp and cannabis industries and a leading manufacturer of hemp-derived cannabidiol (CBD) products such as Pure CBD Oil, Full Spectrum CBD Oil, CBD Topicals, CBD For Pets and CBD for Horses.

Recent Developments in Global Cannabis Industry Resulting in Strains With Higher CBD Levels

Retrieved on: 
Tuesday, February 12, 2019

Research by the University College Londonalso suggests that people who smoke cannabis rich in CBD are less likely to experience "schizophrenia-likesymptoms" than those who smoke cannabis containing only THC.

Key Points: 
  • Research by the University College Londonalso suggests that people who smoke cannabis rich in CBD are less likely to experience "schizophrenia-likesymptoms" than those who smoke cannabis containing only THC.
  • The origins of modern cannabis can be traced to California in the late 1970s, when professional breeders began to select the most potent, THC-rich plants for the first time.
  • The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX: TGODF) the company recently announced that it had secured a cannabis supply agreement with the Ontario Cannabis Retail Corporation."
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Recent Developments in Global Cannabis Industry Resulting in Strains With Higher CBD Levels

Retrieved on: 
Tuesday, February 12, 2019

Research by the University College Londonalso suggests that people who smoke cannabis rich in CBD are less likely to experience "schizophrenia-likesymptoms" than those who smoke cannabis containing only THC.

Key Points: 
  • Research by the University College Londonalso suggests that people who smoke cannabis rich in CBD are less likely to experience "schizophrenia-likesymptoms" than those who smoke cannabis containing only THC.
  • The origins of modern cannabis can be traced to California in the late 1970s, when professional breeders began to select the most potent, THC-rich plants for the first time.
  • The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX: TGODF) the company recently announced that it had secured a cannabis supply agreement with the Ontario Cannabis Retail Corporation."
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

CBD Products Gain Attention as Chronic Pain Incidences Rises

Retrieved on: 
Monday, February 11, 2019

Within the U.S., approximately 70 million suffered from moderate to high levels of chronic pain in 2016, according to data by the National Health Interview Survey.

Key Points: 
  • Within the U.S., approximately 70 million suffered from moderate to high levels of chronic pain in 2016, according to data by the National Health Interview Survey.
  • States are also allowing the use of many cannabis derivatives, such as CBD (cannabidiol), CBN (cannabinol) and THC (delta-9-tetrahydrocannabinol).
  • CBD is one of the fastest growing segments in the cannabis market because it is the non-psychoactive derivative of cannabis and companies involved in both the medical and recreational markets are using CBD within their products.
  • "There are two markets for CBD: as a supplement, mild pain reliever and relaxant, and in larger doses, as a truly beneficial remedy for a variety of serious illnesses.

CBD Products Gain Attention as Chronic Pain Incidences Rises

Retrieved on: 
Monday, February 11, 2019

Within the U.S., approximately 70 million suffered from moderate to high levels of chronic pain in 2016, according to data by the National Health Interview Survey.

Key Points: 
  • Within the U.S., approximately 70 million suffered from moderate to high levels of chronic pain in 2016, according to data by the National Health Interview Survey.
  • States are also allowing the use of many cannabis derivatives, such as CBD (cannabidiol), CBN (cannabinol) and THC (delta-9-tetrahydrocannabinol).
  • CBD is one of the fastest growing segments in the cannabis market because it is the non-psychoactive derivative of cannabis and companies involved in both the medical and recreational markets are using CBD within their products.
  • "There are two markets for CBD: as a supplement, mild pain reliever and relaxant, and in larger doses, as a truly beneficial remedy for a variety of serious illnesses.

Consumers Turn to CBD Products Due to their Non-Psychoactive Nature

Retrieved on: 
Friday, February 8, 2019

CBD is known to offer therapeutic effects just like tetrahydrocannabinol, or THC, however, CBD is the non-psychoactive derivative of cannabis.

Key Points: 
  • CBD is known to offer therapeutic effects just like tetrahydrocannabinol, or THC, however, CBD is the non-psychoactive derivative of cannabis.
  • CBD is also legally available within the U.S. as long as it contains 0.3% or less THC, making it very accessible for consumers.
  • Products such as beverages, creams and flowers are becoming widely popular whether they are being used for medicinal or recreational purposes.
  • I have never seen anything like the explosion that we're seeing right now in CBD, even with the bizarre legal gray area where CBD now operates."

Consumers Turn to CBD Products Due to their Non-Psychoactive Nature

Retrieved on: 
Friday, February 8, 2019

CBD is known to offer therapeutic effects just like tetrahydrocannabinol, or THC, however, CBD is the non-psychoactive derivative of cannabis.

Key Points: 
  • CBD is known to offer therapeutic effects just like tetrahydrocannabinol, or THC, however, CBD is the non-psychoactive derivative of cannabis.
  • CBD is also legally available within the U.S. as long as it contains 0.3% or less THC, making it very accessible for consumers.
  • Products such as beverages, creams and flowers are becoming widely popular whether they are being used for medicinal or recreational purposes.
  • I have never seen anything like the explosion that we're seeing right now in CBD, even with the bizarre legal gray area where CBD now operates."